Acamprosate Calcium (Glenmark Pharmaceuticals Inc., USA)
Welcome to the PulseAid listing for the Acamprosate Calcium drug offered from Glenmark Pharmaceuticals Inc., USA. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Glenmark Pharmaceuticals Inc., USA |
NON-PROPRIETARY NAME: | Acamprosate Calcium |
SUBSTANCE NAME: | ACAMPROSATE CALCIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, DELAYED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-07-16 |
END MARKETING DATE: | 0000-00-00 |
Acamprosate Calcium HUMAN PRESCRIPTION DRUG Details:
Item Description | Acamprosate Calcium from Glenmark Pharmaceuticals Inc., USA |
LABELER NAME: | Glenmark Pharmaceuticals Inc., USA |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 333(mg/1) |
START MARKETING DATE: | 2013-07-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68462-435_94639188-9f3b-47ad-b9a6-eb4de631ac6b |
PRODUCT NDC: | 68462-435 |
APPLICATION NUMBER: | ANDA202229 |
Other ACAMPROSATE CALCIUM Pharmaceutical Manufacturers / Labelers: